By means of its anti-angiogenic activity, thrombospondin-1 (TSP-1) exerts indirect antitumoral action on solid tumors. Here, we investigated potential antitumor action in an in vitro cell model for promyelocytic leukemia (NB4-LR1), resistant to retinoid maturation.
INTRODUCTION
Cell interaction with extracellular matrix proteins is essential to regulate proliferation, differentiation and cell death. [1] [2] [3] Thrombospondin-1 (TSP-1) belongs to a family of multidomain and multifunctional glycoproteins that regulate cell proliferation, migration, differentiation and is important for embryonic development, morphogenesis, inflammation, tumor metastasis and multiple other processes. [4] [5] [6] TSP-1 is a secreted component of extracellular matrix that supports attachment and motility of a variety of normal and neoplastic cell types. 5, 7, 8 Since it also functions as soluble protein that antagonizes the proadhesive activities of other matrix proteins, TSP-1 has been defined as a matricellular protein, modulating cell-matrix interactions. 9, 10 It can affect matrix structure through its ability to interact with matrix components and to activate TGF-β1. 11 TSP-1 is also a potent physiological inhibitor of angiogenesis by impairing endothelial cell growth and migration and by acting on endothelial cell cycle progression and apoptosis, then down-expression of TSP-1 is important for tumor progression. [12] [13] [14] [15] Many of the TSP-1 functions have been located within specific domains of the molecule which bind to various membrane receptors including integrins of the β1 and β3 family, CD47/IAP (integrin-associated protein), CD36 and proteoglycans. 5, 8 Therefore, cell responses to TSP-1 probably reflect the integration of multiple membrane signals depending on the cell type and its repertoire in membrane receptors.
TSP-1 function in tumor cell differentiation and apoptosis remains poorly explored.
TSP-1 has been described to be positively involved in retinoic acid-induced maturation of neuroblastoma cells and the acute myeloblastic leukemic cell line HL-60. 16, 17 In the HL60 cell line, it was shown to induce a caspase-dependent cell death mediated by CD36. 18 It is also able to trigger a caspase-independent cell death that is accompanied by selective mitochondrial changes in B-chronic lymphocytic leukemia through binding to CD47. 19, 20 TSP-1 also induces CD47-mediated killing of breast cancer cells acting via heterotrimeric Gidependent inhibition of protein kinase A activity. 21 NB4 cells have been derived from leukemic cells of a patient with acute promyelocytic leukemia (APL) 22 and carry the characteristic t(15;17) translocation giving rise to the expression of the retinoic acid receptor fusion protein (PML-RARα). 23, 24 Pharmacologic doses of all-trans retinoic acid (ATRA) can convert the fusion protein into an
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From active receptor and restore granulocytic maturation of these cells, so that its administration to APL patients either alone or combined with chemotherapy is of therapeutic benefit and improve the survival prognosis. 25, 26 The NB4-LR1 cell subline is resistant to maturation by ATRA, and was isolated from the early culture of NB4 cells derived from leukemic cells of the APL patient. 27 It was found that NB4-LR1 cells required cAMP analog and ATRA signaling cross-talk to undertake granulocytic maturation program, suggesting interdependent ATRA and cAMP signaling pathways in acute promyelocytic leukemia maturation. 28 Noteably, a wide spectrum of membrane signals have been shown to modulate or to cooperate with retinoids to induce, in NB4 leukemic cells, maturation or cell death independently of maturation. 29 No investigation has been carried out so far to know whether biological response to TSP-1 signalling could be exploited in APL.
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METHODS

Cell culture and treatment
The APL cell line NB4 and the resistant APL cell line NB4-LR1 were essentially cultured in RPMI 1640 medium (Invitrogen, Carlsbad, CA) as previously described. 22 
Purified TSP-1 and TSP-1 recombinant fragments
Human TSP-1 was purified from the supernatant of thrombin-activated platelets as previously described. 30 Recombinant proteins including specific sequences for the NH 2 -terminal (NTSP-1), the three type 1 repeats (3TSR) and the type 3 repeat/C-terminal domain (T3C1) of TSP-1 were produced in Drosophilia S2 cells. The preparation of 3TSR has been described previously. 31 NTSP-1 was prepared using the forward primer 573htsp1f (GAT GAT CCA TGG AAC CGC ATT CCA GAG TCT GGC) and the reverse primer 574htsp1r (GAT ACC GGT GTT AGT GCG GAT GGC AGG GCT). The PCR product was sequenced and cloned between the NcoI and the AgeI sites of the vector pMT/BiP/V5-HisA (Invitrogen). The recombinant protein includes the vector-derived sequence RSPW at the N-terminal. T3C1 was prepared using the forward primer 575htsp1f (GAT GAT CCC GGG GAC ACA GAC CTG GAT GGC TGG) and the reverse primer 576htsp1r (GAT ACC GGT GGG ATC TCT ACA TTC GTA TTT). The PCR product was sequenced and cloned between the XmaI and the AgeI sites of the above vector. The recombinant protein includes the sequence RSPWPG at the Nterminal. All of the recombinant proteins contain the sequence TGHHHHHH at the Cterminal. Vector transfection, cell selection and protein expression and purification were performed as described previously. 
Subcellular fractionation
Cells in PBS were resuspended in buffer (250 mM sucrose, 10 mM KCl, 1 mM MgCl 2 , 1.5 mM EDTA, 1.5 mM EGTA, 1 mM DTT, 20 mM Hepes pH 7.4, 0.1 mM PMSF and 10 µg/ml leupeptin, sodium orthovanadate, sodium fluoride and benzamidine) for 20 min on ice, then lysed using a Dounce tissue grinder. Nuclei and unlysed cells were sedimented at 1000 g for 10 min and the supernatant was centrifuged at 100,000 g to recover organelle-and 
Assays for cell death
Annexin V binding and propidium iodide (PI) staining
Cell death was assessed by analysing phosphatidylserine (PS) membrane outside exposure and cell membrane permeability 36,37 by flow cytometry, using an apoptosis detection kit (Bender MedSystems, Vienna, Austria) for cell double labeling with 1 µg/mL FITClabeled annexin V and PI.
Caspase activity
Caspase-3 activity was measured on cell extract (20-50 µg) by a colorimetric procedure using the specific peptide substrate DEVD-pNa, as described.
38
DNA fragmentation
DNA was isolated from 2x10 6 cells according to a salting out procedure previously described, 39 and internucleosomal fragmentation was analysed as already reported. Potential membrane receptors for TSP-1, such as CD47, the β1 and β3 integrin families were similarly expressed in NB4 and NB4-LR1 cells. Expression of these membrane markers was not modulated by ATRA treatment ( Figure 1D ), contrasting with the leukocyte β2 integrin, CD11c, for which membrane expression was reported to be upregulated. 28, 41 Note that the two cell lines were negative for CD36.
We therefore investigated whether TSP-1, upon its synthesis and secretion induced by Figure   2C ).
Finally, T3C1 treatment also induced maturation-independent cell death, as evaluated through NBT dye reduction and MGG staining assays (not shown). In addition, condensed chromatin or fragmented nuclei were not observed upon Dapi staining of the cells ( Figure   3D ).
Caspase-independent cell death induced by TSP-1 in NB4-LR1 cells
We next investigated the involvement of caspase activity in cell death triggered by TSP-1 by comparison with staurosporine, a well known inducer of cell apoptosis. Figure 4A ). In addition, we found that the broad spectrum caspase inhibitor z-VAD-fmk, used at a non-cytotoxic dose . 36 As shown in Figure 5A , kinetics analysis showed a drop in ∆Ψm of T3C1-or ATRA/T3C1-treated cells, that was detected at day 2 and was more pronounced at day 3. Importantly, ATRA by itself had only very slight effect on ∆Ψm reduction, and staurosporine was found to induce a drop in ∆Ψm similar to that detected after T3C1 treatment (not shown).
Mitochondria are the major source of reactive oxygen species (ROS) which intracellular accumulation, upon ∆Ψm disruption, induces cellular oxydative stress that is implicated both in apoptosis and necrosis. 36,37 Intracellular ROS production upon T3C1/ATRA treatment was detected at day 2 in close correlation with loss of ∆Ψm, and was essentially due to the T3C1 fragment effect ( Figure 5B ). The lower level of ROS observed at day 3 was very likely resulting from ROS leakage due to membrane alterations. Pretreatment of the cells with selenium, known to reduce oxidative stress or Ebselen, a seleno-organic compound that converts H 2 O 2 to H 2 O, 43 showed no inhibitory effect, indicating that mitochondria-derived ROS were likely not involved in the cell death process induced by T3C1 ( Figure 5C ).
We then examined whether cytochrome c was released from mitochondria which release process is independent of caspase activity and needs outer membrane permeabilization without mitochondrial depolarization. 44 Whereas cytosolic accumulation of cytochrome c was clearly detected in staurosporine-treated NB4-LR1 cells through subcellular analysis, it was undetected in T3C1-treated cells ( Figure 6A ). Supporting this finding, immunofluorescence analysis indicated no change in cytochrome c subcellular localization after T3C1/ATRA treatment, as illustrated in Figure 6B , whereas staurosporine treatment clearly induced change in subcellular distribution. Mitochondrial release of other soluble intermembrane proteins that occurrs upon ∆Ψm loss and contributes to both caspase-independent (endonuclease G, AIF, Omi/HtrA2) or caspase-dependent (Smac-Diablo) cell death processes 45, 46 was also examined by immunofluorescence ( Figure 6B ). Collectively, these data indicated no mitochondrial release upon T3C1 action CD47 and αvβ3 integrin receptors mediate cell death induced by the TSP-1
C-terminal domain
Given that the T3C1 recombinant fragment contains both TSP-1 binding sequences to CD47 and αvβ3 receptors (see Figure 3A) , 8 involvement of these receptors in the death responses of NB4-LR1 cells to T3C1 was next examined.
At first, immunofluorescence experiments were performed that showed colocalization of αvβ3 with CD47 in the membrane of untreated or ATRA-treated NB4-LR1 cells, as illustrated in Figure 7A Further experiments were carried out using the CD47 agonist peptide RFYVVMWK (4N1-1) from the C-terminal domain of TSP-1, 47 and the GRGDS peptide mimetic for the αvβ3-binding activity of the RGDA sequence identified from type 3-repeat domain of TSP-1. 30 The VTCG peptide corresponding to a binding sequence of TSP-1 for CD36 was used as peptide control. The VTCG sequence is not present in the T3C1 fragment and CD36 is not expressed in NB4 cells (see Figures 1D and 3A) . The 4N1-1, GRGDS and VTCG peptides alone were not found to have death induction effect on either untreated or ATRA-treated
NB4-LR1 cells, through cell microscopic observation and PS positive detection (not shown).
In addition, all the peptides did not display significant cell growth inhibitory effect. When tested for their ability to interfere with the effect of T3C1 by itself or combined with ATRA, the 4N1-1 and GRGDS peptides were found to exert dose-dependent inhibitory action on cell killing, as quantified by annexin V cell staining at day 4. The GRGDS peptide showed a stronger action than 4N1-1, while the VTCG control peptide had no significant effect. When added together, the 4N1-1 and GRGDS peptides showed a greater inhibitory effect that was found to be unchanged by ATRA treatment ( Figure 7B ). Furthermore, combinatorial effect of these two peptides measured at day 2 indicated substantial inhibition of NB4-LR1 cell death
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DISCUSSION
In this study, the acute promyelocytic leukemic cell line NB4-LR1, resistant to maturation by ATRA, 28 The mitochondrial dysfunction induced by action of the C-terminal domain of TSP-1 on NB4-LR1 did not lead to cytochrome c or AIF release, as shown in other studies reporting on death effects by CD47 agonists. 20, 21 We extended these studies to other death-promoting factors and found no release of endonuclease G and Omi/HtrA2, or Smac-Diablo. Absence of AIF or endonuclease G leakage is consistent with the absence of chromatin condensation and nuclear fragmentation (see Figure 3D) . 45, 46 On the other hand, mitochondrial ROS accumulation was detected in cells, which function as second messengers and regulating molecules for cell death. 37 However, through use of ROS scavenger or oxidative stress inhibitor, we did not find ROS to be involved in cell damage. This result could be related to the absence of cytochrome c release which preserves normal redox state, 36,37 so that only moderate levels of ROS are produced. It remains to be determined whether a mitochondrial dysfunction featured by a partial (or differential) membrane permeabilization defect could be one rate-limiting step of this TSP-1 dependent cell death.
Finally, many forms of caspase-independent programmed cell death are mediated by other proteases such as cathepsins, calpains, serine proteases that can cleave at least some of the caspase substrates. 38, 50, 51 However, this alternative cell death pathway generally produces mitochondrial intermembrane protein leakage and leads to incomplete chromatin condensation. [52] [53] [54] [55] We investigated the involvement of calpain activity since among numerous calpain substrates are cytoskeletal and membrane-associated proteins suggesting that calpains are important in destruction of cellular architecture. 53, 56 However, no inhibitory effect was Cell death is mediated by the TSP-1 membrane receptors CD47 and the αvβ3 integrin, and is accompanied with ∆Ψm collapse that does not result in the release of well-known deathpromoting proteins, such as the non-caspase apoptosis regulators AIF, endonuclease G or Omi/HtrA2. This kind of cell death may resemble in some way necrosis-like programmed cell death in which increased PS membrane exposure is detected in the absence of chromatin condensation and occurs before cell damage. 50 However, the level of necrosis is low and not consistent with the apparent substantial cell damage, suggesting it could not be a major event,
and cell death might actually be related to an alternative, unidentified, process.
Retinoids have important physiological functions in regulating cell growth, differentiation and death. 57 Upon its induction and secretion following ATRA treatment, TSP- 
